Annual CFO
-$20.03 M
+$1.14 M+5.38%
31 December 2023
Summary:
Lisata Therapeutics annual cash flow from operations is currently -$20.03 million, with the most recent change of +$1.14 million (+5.38%) on 31 December 2023. During the last 3 years, it has fallen by -$11.21 million (-127.04%). LSTA annual CFO is now -2092.44% below its all-time high of $1.01 million, reached on 01 December 2002.LSTA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.52 M
+$2.77 M+52.34%
30 September 2024
Summary:
Lisata Therapeutics quarterly cash flow from operations is currently -$2.52 million, with the most recent change of +$2.77 million (+52.34%) on 30 September 2024. Over the past year, it has increased by +$1.06 million (+29.72%). LSTA quarterly CFO is now -155.92% below its all-time high of $4.50 million, reached on 01 June 2020.LSTA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$18.90 M
+$1.06 M+5.34%
30 September 2024
Summary:
Lisata Therapeutics TTM cash flow from operations is currently -$18.90 million, with the most recent change of +$1.06 million (+5.34%) on 30 September 2024. Over the past year, it has increased by +$3.53 million (+15.75%). LSTA TTM CFO is now -1671.61% below its all-time high of $1.20 million, reached on 01 March 2003.LSTA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.4% | +29.7% | +15.8% |
| 3 y3 years | -127.0% | +50.0% | +18.6% |
| 5 y5 years | -0.2% | +43.5% | -6.7% |
LSTA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -127.0% | +9.9% | at high | +69.3% | -0.2% | +20.4% |
| 5 y | 5 years | -127.0% | +9.9% | -155.9% | +69.3% | -152.8% | +20.4% |
| alltime | all time | -2092.4% | +57.3% | -155.9% | +82.3% | -1671.6% | +62.1% |
Lisata Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.52 M(-52.3%) | -$18.90 M(-5.3%) |
| June 2024 | - | -$5.28 M(-24.8%) | -$19.96 M(+5.8%) |
| Mar 2024 | - | -$7.03 M(+72.7%) | -$18.86 M(-5.8%) |
| Dec 2023 | -$20.03 M(-5.4%) | -$4.07 M(+13.6%) | -$20.03 M(-10.7%) |
| Sept 2023 | - | -$3.58 M(-14.4%) | -$22.43 M(-1.8%) |
| June 2023 | - | -$4.18 M(-49.0%) | -$22.85 M(-3.7%) |
| Mar 2023 | - | -$8.20 M(+26.7%) | -$23.72 M(+12.1%) |
| Dec 2022 | -$21.17 M(-4.8%) | -$6.47 M(+61.8%) | -$21.17 M(+9.7%) |
| Sept 2022 | - | -$4.00 M(-21.0%) | -$19.31 M(-5.1%) |
| June 2022 | - | -$5.06 M(-10.3%) | -$20.35 M(+2.2%) |
| Mar 2022 | - | -$5.64 M(+22.5%) | -$19.91 M(-10.5%) |
| Dec 2021 | -$22.25 M(+152.1%) | - | - |
| Dec 2021 | - | -$4.60 M(-8.6%) | -$22.25 M(-4.1%) |
| Sept 2021 | - | -$5.04 M(+8.9%) | -$23.21 M(+7.0%) |
| June 2021 | - | -$4.63 M(-42.0%) | -$21.69 M(+72.7%) |
| Mar 2021 | - | -$7.97 M(+43.3%) | -$12.56 M(+42.3%) |
| Dec 2020 | -$8.82 M(-53.3%) | -$5.57 M(+58.2%) | -$8.82 M(+18.0%) |
| Sept 2020 | - | -$3.52 M(-178.1%) | -$7.48 M(-11.2%) |
| June 2020 | - | $4.50 M(-206.2%) | -$8.41 M(-52.3%) |
| Mar 2020 | - | -$4.24 M(+0.5%) | -$17.64 M(-6.6%) |
| Dec 2019 | -$18.88 M(-5.5%) | -$4.22 M(-5.3%) | -$18.88 M(+6.7%) |
| Sept 2019 | - | -$4.46 M(-5.6%) | -$17.70 M(-1.7%) |
| June 2019 | - | -$4.72 M(-14.0%) | -$18.01 M(-6.1%) |
| Mar 2019 | - | -$5.49 M(+80.3%) | -$19.17 M(-4.1%) |
| Dec 2018 | -$19.99 M(-4.3%) | -$3.04 M(-36.1%) | -$19.99 M(-4.4%) |
| Sept 2018 | - | -$4.76 M(-19.1%) | -$20.91 M(-7.0%) |
| June 2018 | - | -$5.88 M(-6.6%) | -$22.48 M(+31.6%) |
| Mar 2018 | - | -$6.30 M(+58.7%) | -$17.09 M(-18.1%) |
| Dec 2017 | -$20.88 M(-11.8%) | -$3.97 M(-37.3%) | -$20.88 M(+2.9%) |
| Sept 2017 | - | -$6.33 M(+1195.8%) | -$20.28 M(+3.1%) |
| June 2017 | - | -$488.50 K(-95.2%) | -$19.67 M(-23.5%) |
| Mar 2017 | - | -$10.09 M(+198.9%) | -$25.73 M(+8.7%) |
| Dec 2016 | -$23.67 M(-39.7%) | -$3.38 M(-41.0%) | -$23.67 M(-18.4%) |
| Sept 2016 | - | -$5.72 M(-12.7%) | -$29.02 M(-9.3%) |
| June 2016 | - | -$6.55 M(-18.4%) | -$32.01 M(-3.1%) |
| Mar 2016 | - | -$8.03 M(-8.0%) | -$33.05 M(-15.8%) |
| Dec 2015 | -$39.26 M(-16.3%) | -$8.73 M(+0.3%) | -$39.26 M(-5.3%) |
| Sept 2015 | - | -$8.70 M(+14.7%) | -$41.43 M(-10.3%) |
| June 2015 | - | -$7.59 M(-46.7%) | -$46.22 M(-7.3%) |
| Mar 2015 | - | -$14.24 M(+30.6%) | -$49.88 M(+6.4%) |
| Dec 2014 | -$46.90 M(+73.0%) | -$10.90 M(-19.1%) | -$46.90 M(+8.2%) |
| Sept 2014 | - | -$13.48 M(+19.8%) | -$43.36 M(+18.8%) |
| June 2014 | - | -$11.25 M(-0.0%) | -$36.48 M(+16.9%) |
| Mar 2014 | - | -$11.25 M(+52.8%) | -$31.22 M(+15.2%) |
| Dec 2013 | -$27.10 M(+95.6%) | -$7.36 M(+11.4%) | -$27.10 M(-7.7%) |
| Sept 2013 | - | -$6.61 M(+10.4%) | -$29.36 M(+12.4%) |
| June 2013 | - | -$5.99 M(-16.1%) | -$26.13 M(+13.1%) |
| Mar 2013 | - | -$7.14 M(-25.9%) | -$23.09 M(+66.7%) |
| Dec 2012 | -$13.85 M(-33.8%) | -$9.62 M(+185.2%) | -$13.85 M(+81.5%) |
| Sept 2012 | - | -$3.38 M(+14.1%) | -$7.63 M(-10.4%) |
| June 2012 | - | -$2.96 M(-240.5%) | -$8.51 M(-1.3%) |
| Mar 2012 | - | $2.11 M(-161.9%) | -$8.63 M(-58.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$20.93 M(+146.9%) | -$3.41 M(-20.0%) | -$20.93 M(-8.3%) |
| Sept 2011 | - | -$4.26 M(+38.6%) | -$22.82 M(+24.9%) |
| June 2011 | - | -$3.07 M(-69.9%) | -$18.28 M(+13.6%) |
| Mar 2011 | - | -$10.20 M(+92.3%) | -$16.09 M(+89.8%) |
| Dec 2010 | -$8.48 M(+1.3%) | -$5.30 M(-1935.5%) | -$8.48 M(+316.4%) |
| Sept 2010 | - | $288.80 K(-132.7%) | -$2.04 M(-69.2%) |
| June 2010 | - | -$882.60 K(-65.8%) | -$6.62 M(-31.8%) |
| Mar 2010 | - | -$2.58 M(-326.5%) | -$9.70 M(+15.9%) |
| Dec 2009 | -$8.37 M(+76.9%) | $1.14 M(-126.6%) | -$8.37 M(-21.2%) |
| Sept 2009 | - | -$4.29 M(+8.1%) | -$10.63 M(+46.5%) |
| June 2009 | - | -$3.97 M(+216.7%) | -$7.26 M(+58.3%) |
| Mar 2009 | - | -$1.25 M(+12.5%) | -$4.58 M(-3.1%) |
| Dec 2008 | -$4.73 M(-22.8%) | -$1.11 M(+21.1%) | -$4.73 M(-9.0%) |
| Sept 2008 | - | -$920.10 K(-29.0%) | -$5.20 M(-16.2%) |
| June 2008 | - | -$1.30 M(-7.5%) | -$6.21 M(+6.4%) |
| Mar 2008 | - | -$1.40 M(-11.5%) | -$5.83 M(-4.9%) |
| Dec 2007 | -$6.13 M(+68.5%) | -$1.58 M(-17.7%) | -$6.13 M(+15.3%) |
| Sept 2007 | - | -$1.92 M(+108.4%) | -$5.32 M(+18.8%) |
| June 2007 | - | -$923.60 K(-45.7%) | -$4.48 M(-0.7%) |
| Mar 2007 | - | -$1.70 M(+120.5%) | -$4.51 M(+24.0%) |
| Dec 2006 | -$3.64 M(+336.3%) | -$771.10 K(-28.9%) | -$3.64 M(+12.9%) |
| Sept 2006 | - | -$1.08 M(+13.4%) | -$3.22 M(+41.1%) |
| June 2006 | - | -$955.90 K(+15.5%) | -$2.29 M(+45.8%) |
| Mar 2006 | - | -$827.70 K(+132.2%) | -$1.57 M(+87.9%) |
| Dec 2005 | -$834.00 K(-42.9%) | -$356.50 K(+146.0%) | -$834.00 K(+2.1%) |
| Sept 2005 | - | -$144.90 K(-39.1%) | -$817.10 K(-20.4%) |
| June 2005 | - | -$238.10 K(+152.0%) | -$1.03 M(-11.3%) |
| Mar 2005 | - | -$94.50 K(-72.2%) | -$1.16 M(-20.7%) |
| Dec 2004 | -$1.46 M(+42.8%) | -$339.60 K(-4.3%) | -$1.46 M(+14.0%) |
| Sept 2004 | - | -$354.90 K(-3.8%) | -$1.28 M(-20.5%) |
| June 2004 | - | -$368.90 K(-6.9%) | -$1.61 M(+18.6%) |
| Mar 2004 | - | -$396.20 K(+146.7%) | -$1.36 M(+33.0%) |
| Dec 2003 | -$1.02 M(-201.6%) | -$160.60 K(-76.6%) | -$1.02 M(-265.7%) |
| Sept 2003 | - | -$685.40 K(+486.8%) | $616.60 K(-48.4%) |
| June 2003 | - | -$116.80 K(+97.6%) | $1.19 M(-0.6%) |
| Mar 2003 | - | -$59.10 K(-104.0%) | $1.20 M(+19.6%) |
| Dec 2002 | $1.01 M(-369.0%) | $1.48 M(-1478.6%) | $1.01 M(+934.4%) |
| Sept 2002 | - | -$107.20 K(-1.8%) | $97.20 K(-181.3%) |
| June 2002 | - | -$109.20 K(-57.4%) | -$119.50 K(-55.2%) |
| Mar 2002 | - | -$256.10 K(-145.0%) | -$266.80 K(-28.6%) |
| Dec 2001 | -$373.80 K(-83.9%) | $569.70 K(-275.9%) | -$373.90 K(-73.4%) |
| Sept 2001 | - | -$323.90 K(+26.3%) | -$1.41 M(-21.8%) |
| June 2001 | - | -$256.50 K(-29.4%) | -$1.80 M(-12.1%) |
| Mar 2001 | - | -$363.20 K(-21.4%) | -$2.05 M(-12.1%) |
| Dec 2000 | -$2.33 M(-12.9%) | -$461.90 K(-35.5%) | -$2.33 M(+24.8%) |
| Sept 2000 | - | -$715.60 K(+41.8%) | -$1.87 M(+62.2%) |
| June 2000 | - | -$504.80 K(-21.7%) | -$1.15 M(+78.3%) |
| Mar 2000 | - | -$644.80 K | -$644.80 K |
| Dec 1999 | -$2.67 M(+726.5%) | - | - |
| Dec 1998 | -$323.10 K(+19.8%) | - | - |
| Mar 1998 | -$269.60 K(-11.4%) | - | - |
| Mar 1997 | -$304.30 K(-63.7%) | - | - |
| Mar 1996 | -$838.40 K | - | - |
FAQ
- What is Lisata Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Lisata Therapeutics?
- What is Lisata Therapeutics annual CFO year-on-year change?
- What is Lisata Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly CFO year-on-year change?
- What is Lisata Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Lisata Therapeutics?
- What is Lisata Therapeutics TTM CFO year-on-year change?
What is Lisata Therapeutics annual cash flow from operations?
The current annual CFO of LSTA is -$20.03 M
What is the all time high annual CFO for Lisata Therapeutics?
Lisata Therapeutics all-time high annual cash flow from operations is $1.01 M
What is Lisata Therapeutics annual CFO year-on-year change?
Over the past year, LSTA annual cash flow from operations has changed by +$1.14 M (+5.38%)
What is Lisata Therapeutics quarterly cash flow from operations?
The current quarterly CFO of LSTA is -$2.52 M
What is the all time high quarterly CFO for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly cash flow from operations is $4.50 M
What is Lisata Therapeutics quarterly CFO year-on-year change?
Over the past year, LSTA quarterly cash flow from operations has changed by +$1.06 M (+29.72%)
What is Lisata Therapeutics TTM cash flow from operations?
The current TTM CFO of LSTA is -$18.90 M
What is the all time high TTM CFO for Lisata Therapeutics?
Lisata Therapeutics all-time high TTM cash flow from operations is $1.20 M
What is Lisata Therapeutics TTM CFO year-on-year change?
Over the past year, LSTA TTM cash flow from operations has changed by +$3.53 M (+15.75%)